Amaro Flavia, Chiarelli Francesco
Department of Pediatrics, University of Chieti, 66013 Chieti, Italy.
Biomedicines. 2020 Oct 29;8(11):458. doi: 10.3390/biomedicines8110458.
Inflammatory bowel diseases (IBD) are gastrointestinal tract pathologies of unknown etiology; they have an alternating trend, with active and silent phases. IBD are classified in two main forms: ulcerative colitis (UC) and Crohn's disease (CD). Both have chronic and recurrent course, gastrointestinal symptoms, and extraintestinal manifestations. The altered immune response role seems to be important both in UC and CD. In the majority of cases, CD begins with abdominal pain, diarrhea, decrease in appetite, and weight loss; there can be also perianal fistulas, rhagades, and perianal recurrent abscesses. In addition, retarded growth and delayed puberty can precede the development of the disease or can even be predominant at onset. Growth retardation is found in 40% of IBD patients, but the underlying mechanism of this and other extra-intestinal manifestations are partially known: the main hypotheses are represented by malnutrition and inflammatory response during the active phase of the disease. The increased level of pro-inflammatory cytokines can influence growth, but also the onset of puberty and its progression. In addition, it could be essential to clarify the role and the possible effects of all the currently used treatments concerning growth failure and delayed puberty.
炎症性肠病(IBD)是病因不明的胃肠道疾病;它们具有交替趋势,有活动期和静止期。IBD主要分为两种形式:溃疡性结肠炎(UC)和克罗恩病(CD)。两者都有慢性和复发性病程、胃肠道症状以及肠外表现。免疫反应改变在UC和CD中似乎都很重要。在大多数情况下,CD始于腹痛、腹泻、食欲减退和体重减轻;也可能出现肛周瘘管、皲裂和肛周复发性脓肿。此外,生长发育迟缓及青春期延迟可能在疾病发生之前出现,甚至在发病时占主导。40%的IBD患者存在生长发育迟缓,但这种情况及其他肠外表现的潜在机制部分已知:主要假说是疾病活动期的营养不良和炎症反应。促炎细胞因子水平升高会影响生长,也会影响青春期的开始及其进展。此外,阐明目前所有用于治疗生长发育障碍和青春期延迟的治疗方法的作用及可能效果可能至关重要。